CoChat

The effect of DPP‐4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose

Open access
Bock, Gerlies, Man, Chiara Dalla, Micheletto, Francesco, Basu, Rita, Giesler, Paula D., Laugen, Jeanette, Deacon, Carolyn F., Holst, Jens J., Toffolo, Gianna, Cobelli, Claudio, Rizza, Robert A., Vella, Adrian · 2010 · Clinical Endocrinology
Cited by 71

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Objective Low glucagon‐like peptide‐1 (GLP‐1) concentrations have been observed in impaired fasting glucose (IFG). It is uncertain whether these abnormalities contribute directly to the pathogenesis of IFG and impaired glucose tolerance. Dipeptidyl peptidase‐4 (DPP‐4) inhibitors raise incretin hormone concentrations enabling an examination of their effects on glucose turnover in IFG. Research design and methods We studied 22 subjects with IFG using a double‐blinded, placebo‐controlled, parallel‐group design. At the time of enrolment, subjects ate a standardized meal labelled with [1‐13 C]‐glucose. Infused [6‐3 H] glucose enabled measurement of systemic meal appearance (MRa). Infused [6,6‐2 H 2] glucose enabled measurement of endogenous glucose production (EGP) and glucose disappearance (Rd). Subsequently, subjects were randomized to 100 mg of sitagliptin daily or placebo. After an 8‐week treatment period, the mixed meal was repeated. Results As expected, subjects with IFG who received placebo did not experience any change in glucose concentrations. Despite raising intact GLP‐1 concentrations, treatment with sitagliptin did not alter either fasting or postprandial glucose, insulin or C‐peptide concentrations. Postprandial EGP (18·1 ± 0·7 vs 17·6 ± 0·8 μmol/kg per min, P = 0·53), Rd (55·6 ± 4·3 vs 58·9 ± 3·3 μmol/kg per min, P = 0·47) and MRa (6639 ± 377 vs 6581 ± 316 μmol/kg per 6 h, P = 0·85) were unchanged. Sitagliptin was associated with decreased total GLP‐1 implying decreased incretin secretion. Conclusions DPP‐4 inhibition did not alter fasting or postprandial glucose turnover in people with IFG. Low incretin concentrations are unlikely to be involved in the pathogenesis of IFG.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2009.03764.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 71

Metadata

Authors
Bock, G., Man, C. D., Micheletto, F., Basu, R., Giesler, P. D., Laugen, J., Deacon, C. F., Holst, J. J., Toffolo, G., Cobelli, C., Rizza, R. A., & Vella, A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2010-07-21
Volume
73
Issue
2
Pages
189-196
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2125884659
Cited by
71
References
6
FWCI
3.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of DPP‐4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. https://app.cochat.ai/papers/10.1111/j.1365-2265.2009.03764.x
The paper
Bock, G., Man, C. D., Micheletto, F., Basu, R., Giesler, P. D., Laugen, J., Deacon, C. F., Holst, J. J., Toffolo, G., Cobelli, C., Rizza, R. A., & Vella, A. (2010). The effect of DPP‐4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2009.03764.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.